Cargando…
KDM5B demethylates H3K4 to recruit XRCC1 and promote chemoresistance
Chemotherapy is the main treatment for human cancers including gastric cancer. However, in response to chemotherapeutic drugs, tumor cells can develop drug resistance by reprogramming intracellular metabolic and epigenetic networks to maintain their intrinsic homeostasis. Previously, we have establi...
Autores principales: | Xu, Wenxia, Zhou, Bingluo, Zhao, Xiaoya, Zhu, Liyuan, Xu, Jinye, Jiang, Zhinong, Chen, Dingwei, Wei, Qi, Han, Mengjiao, Feng, Lifeng, Wang, Shouyu, Wang, Xian, Zhou, Jianwei, Jin, Hongchuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6036731/ https://www.ncbi.nlm.nih.gov/pubmed/29989047 http://dx.doi.org/10.7150/ijbs.25881 |
Ejemplares similares
-
Hypoxia Stimulates SUMOylation-Dependent Stabilization of KDM5B
por: Zhou, Bingluo, et al.
Publicado: (2021) -
SIRT1 deacetylated and stabilized XRCC1 to promote chemoresistance in lung cancer
por: Yousafzai, Neelum Aziz, et al.
Publicado: (2019) -
CCL2-SQSTM1 positive feedback loop suppresses autophagy to promote chemoresistance in gastric cancer
por: Xu, Wenxia, et al.
Publicado: (2018) -
Enolase 1 stimulates glycolysis to promote chemoresistance in gastric cancer
por: Qian, Xiaoling, et al.
Publicado: (2017) -
LncRNA LINC00942 promotes chemoresistance in gastric cancer by suppressing MSI2 degradation to enhance c‐Myc mRNA stability
por: Zhu, Yiran, et al.
Publicado: (2022)